Form 8.3 - International Paper Company

LONDON--()-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26-11-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

7,166,114

2.06

(2) Cash-settled derivatives:

 

0

0.0

0

0.0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

10,400

0.003

9,100

0.002

 

TOTAL:

10,400

0.003

7,175,214

2.06

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

51

59.09

Common Stock

Sale

52

58.65

Common Stock

Sale

54

59.23

Common Stock

Sale

55

59.03

Common Stock

Sale

68

59.14

Common Stock

Sale

100

58.71

Common Stock

Sale

100

58.72

Common Stock

Sale

100

58.74

Common Stock

Sale

100

58.78

Common Stock

Sale

100

58.95

Common Stock

Sale

100

58.96

Common Stock

Sale

100

59.00

Common Stock

Sale

100

59.02

Common Stock

Sale

100

59.12

Common Stock

Sale

118

59.07

Common Stock

Sale

138

59.24

Common Stock

Sale

139

59.13

Common Stock

Sale

155

59.44

Common Stock

Sale

160

59.25

Common Stock

Sale

163

58.90

Common Stock

Sale

175

59.16

Common Stock

Sale

200

58.70

Common Stock

Sale

200

58.73

Common Stock

Sale

200

59.06

Common Stock

Sale

226

59.04

Common Stock

Sale

300

58.97

Common Stock

Sale

400

58.93

Common Stock

Sale

400

59.05

Common Stock

Sale

400

59.71

Common Stock

Sale

4356

59.11

Common Stock

Purchase

13

58.75

Common Stock

Purchase

15

58.95

Common Stock

Purchase

20

59.26

Common Stock

Purchase

24

58.83

Common Stock

Purchase

25

58.70

Common Stock

Purchase

34

59.64

Common Stock

Purchase

39

58.91

Common Stock

Purchase

43

59.31

Common Stock

Purchase

44

59.12

Common Stock

Purchase

47

59.22

Common Stock

Purchase

60

58.66

Common Stock

Purchase

60

58.68

Common Stock

Purchase

62

58.81

Common Stock

Purchase

62

58.93

Common Stock

Purchase

68

59.12

Common Stock

Purchase

69

59.34

Common Stock

Purchase

83

58.78

Common Stock

Purchase

84

59.11

Common Stock

Purchase

100

58.64

Common Stock

Purchase

100

59.04

Common Stock

Purchase

100

59.28

Common Stock

Purchase

100

59.61

Common Stock

Purchase

103

58.80

Common Stock

Purchase

125

59.30

Common Stock

Purchase

127

59.50

Common Stock

Purchase

131

58.82

Common Stock

Purchase

138

58.70

Common Stock

Purchase

173

59.23

Common Stock

Purchase

191

58.65

Common Stock

Purchase

197

59.26

Common Stock

Purchase

200

58.77

Common Stock

Purchase

200

58.84

Common Stock

Purchase

213

58.77

Common Stock

Purchase

232

59.24

Common Stock

Purchase

247

59.04

Common Stock

Purchase

290

59.18

Common Stock

Purchase

300

59.05

Common Stock

Purchase

305

58.85

Common Stock

Purchase

310

58.81

Common Stock

Purchase

317

58.73

Common Stock

Purchase

320

58.76

Common Stock

Purchase

341

58.74

Common Stock

Purchase

355

59.16

Common Stock

Purchase

486

58.99

Common Stock

Purchase

585

58.98

Common Stock

Purchase

585

59.19

Common Stock

Purchase

594

58.73

Common Stock

Purchase

604

59.07

Common Stock

Purchase

625

58.72

Common Stock

Purchase

644

59.08

Common Stock

Purchase

659

58.92

Common Stock

Purchase

669

58.89

Common Stock

Purchase

707

58.93

Common Stock

Purchase

736

58.91

Common Stock

Purchase

802

59.09

Common Stock

Purchase

805

58.86

Common Stock

Purchase

820

58.79

Common Stock

Purchase

825

58.97

Common Stock

Purchase

848

59.13

Common Stock

Purchase

862

59.21

Common Stock

Purchase

867

58.71

Common Stock

Purchase

991

58.67

Common Stock

Purchase

1060

59.06

Common Stock

Purchase

1069

59.04

Common Stock

Purchase

1109

58.69

Common Stock

Purchase

1124

58.68

Common Stock

Purchase

1191

58.94

Common Stock

Purchase

1389

58.66

Common Stock

Purchase

1452

58.95

Common Stock

Purchase

1745

59.01

Common Stock

Purchase

1798

59.15

Common Stock

Purchase

1897

59.00

Common Stock

Purchase

1927

59.14

Common Stock

Purchase

1939

58.96

Common Stock

Purchase

1948

58.87

Common Stock

Purchase

1997

58.88

Common Stock

Purchase

2467

59.02

Common Stock

Purchase

2521

59.10

Common Stock

Purchase

3839

59.18

Common Stock

Purchase

3966

59.05

Common Stock

Purchase

4522

58.90

Common Stock

Purchase

6304

59.03

Common Stock

Purchase

98376

59.11

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

27-11-2024

Contact name:

Janice Falcao

Telephone number:

00442033140679

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Put Option IP US 12/20/24 P57.5 Equity

Purchase

3,200

USD 57.5

American

12/20/24

Common Stock

Call Option IP US 06/20/25 C52.5 Equity

Purchase

2,000

USD 52.5

American

06/20/25

Common Stock

Call Option IP US 04/17/25 C47.5 Equity

Purchase

1,000

USD 47.5

American

04/17/25

Common Stock

Call Option IP US 10/17/25 C42.5 Equity

Purchase

700

USD 42.5

American

10/17/25

Common Stock

Call Option IP US 04/17/25 C52.5 Equity

Purchase

600

USD 52.5

American

04/17/25

Common Stock

Call Option IP US 09/19/25 C42.5 Equity

Purchase

600

USD 42.5

American

09/19/25

Common Stock

Call Option IP US 10/17/25 C55 Equity

Purchase

500

USD 55

American

10/17/25

Common Stock

Call Option IP US 01/16/26 C50 Equity

Purchase

500

USD 50

American

01/16/26

Common Stock

Call Option IP US 01/16/26 C60 Equity

Purchase

300

USD 60

American

01/16/26

Common Stock

Call Option IP US 06/20/25 C50 Equity

Purchase

300

USD 50

American

06/20/25

Common Stock

Call Option IP US 12/20/24 C50 Equity

Purchase

300

USD 50

American

12/20/24

Common Stock

Call Option IP US 01/17/25 C47.5 Equity

Purchase

200

USD 47.5

American

01/17/25

Common Stock

Call Option IP US 04/17/25 C50 Equity

Purchase

200

USD 50

American

04/17/25

Common Stock

Call Option IP US 01/17/25 C60 Equity

Written

300

USD 60

American

01/17/25

Common Stock

Put Option IP US 04/17/25 P45 Equity

Written

300

USD 45

American

04/17/25

Common Stock

Put Option IP US 01/17/25 P47.5 Equity

Written

400

USD 47.5

American

01/17/25

Common Stock

Call Option IP US 01/17/25 C55 Equity

Written

500

USD 55

American

01/17/25

Common Stock

Call Option IP US 12/20/24 C55 Equity

Written

600

USD 55

American

12/20/24

Common Stock

Put Option IP US 04/17/25 P47.5 Equity

Written

2,400

USD 47.5

American

04/17/25

Common Stock

Put Option IP US 01/16/26 P42.5 Equity

Written

4,600

USD 42.5

American

01/16/26

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

Category Code: RET
Sequence Number: 1262984
Time of Receipt (offset from UTC): 20241127T104853+0000

Contacts

Qube Research & Technologies LTD

Contacts

Qube Research & Technologies LTD